颖泰生物(833819)
主要经济指标
类别\年份 | 营业收入 (元) |
营业利润 (元) |
利润总额 (元) |
净利润 (元) |
资产总计 (元) |
负债合计 (元) |
股东权益合计 (元) |
2013 | 3540000000.0000 | 272000000.0000 | 266000000.0000 | 211000000.0000 | 3733000000.0000 | 1960000000.0000 | 1773000000.0000 |
2014 | 3226000000.0000 | 237000000.0000 | 226000000.0000 | 176000000.0000 | 6919000000.0000 | 5275000000.0000 | 1644000000.0000 |
2015 | 3889000000.0000 | 352000000.0000 | 343000000.0000 | 272000000.0000 | 10521000000.0000 | 6513000000.0000 | 4008000000.0000 |
2016 | 4558000000.0000 | 239000000.0000 | 244000000.0000 | 193000000.0000 | 11681000000.0000 | 7778000000.0000 | 3904000000.0000 |
2017 | 6140000000.0000 | 383000000.0000 | 358000000.0000 | 297000000.0000 | 13768000000.0000 | 9354000000.0000 | 4414000000.0000 |
2018 | 6232000000.0000 | 618000000.0000 | 607000000.0000 | 461000000.0000 | 11866000000.0000 | 7852000000.0000 | 4014000000.0000 |
2019 | 5295000000.0000 | 320000000.0000 | 319000000.0000 | 267000000.0000 | 11307000000.0000 | 7272000000.0000 | 4035000000.0000 |
2020 | 6225000000.0000 | 430000000.0000 | 426000000.0000 | 314000000.0000 | 10726000000.0000 | 6126000000.0000 | 4601000000.0000 |
2021 | 7426000000.0000 | 709000000.0000 | 675000000.0000 | 452000000.0000 | 11936000000.0000 | 7106000000.0000 | 4830000000.0000 |
2022 | 8161000000.0000 | 1446000000.0000 | 1440000000.0000 | 1058000000.0000 | 12551000000.0000 | 6619000000.0000 | 5932000000.0000 |
2023 | 5868000000.0000 | 167000000.0000 | 163000000.0000 | 91174200.0000 | 12642000000.0000 | 6854000000.0000 | 5789000000.0000 |
2024 | 5830000000.0000 | -629000000.0000 | -639000000.0000 | -596000000.0000 | 11906000000.0000 | 6870000000.0000 | 5036000000.0000 |
盈利能力分析
类别\年份 | 销售毛利率 (%) |
营业利润率 (%) |
总资产利润率 (%) |
净资产收益率 | 存货周转率 | 应收账款周转率 (次) |
总资产周转率 (次) |
2013 | 7.60 | 7.51 | 7.13 | 13.1400 | 6.5500 | 3.69 | 0.95 |
2014 | 7.53 | 7.01 | 3.27 | 10.8800 | 5.1200 | 3.90 | 0.47 |
2015 | 9.59 | 8.82 | 3.26 | 10.3600 | 3.9700 | 3.95 | 0.37 |
2016 | 5.46 | 5.35 | 2.09 | 5.5600 | 3.9700 | 3.35 | 0.39 |
2017 | 1.50 | 5.83 | 2.60 | 7.2800 | 3.9600 | 3.48 | 0.45 |
2018 | 7.99 | 9.74 | 5.12 | 10.9200 | 3.2800 | 3.76 | 0.53 |
2019 | 4.80 | 6.02 | 2.82 | 7.0600 | 2.7200 | 4.14 | 0.47 |
2020 | 3.78 | 6.84 | 3.97 | 7.5500 | 3.5600 | 5.89 | 0.58 |
2021 | 5.71 | 9.09 | 5.66 | 10.2800 | 4.0000 | 5.78 | 0.62 |
2022 | 12.61 | 17.64 | 11.47 | 19.5900 | 3.5100 | 6.00 | 0.65 |
2023 | 2.51 | 2.78 | 1.29 | 1.6300 | 2.5800 | 5.30 | 0.46 |
2024 | -7.43 | -10.96 | -5.37 | -10.8700 | 2.9700 | 4.86 | 0.49 |
偿债能力分析
类别\年份 | 资产负债率 (%) |
股东权益比率 (%) |
流动比率 | 速动比率 |
2013 | 52.50 | 47.50 | 1.4200 | 1.0300 |
2014 | 76.24 | 23.76 | 1.4500 | 1.1600 |
2015 | 61.90 | 38.10 | 1.4600 | 1.1900 |
2016 | 66.59 | 33.42 | 0.8700 | 0.6600 |
2017 | 67.94 | 32.06 | 1.1500 | 0.8700 |
2018 | 66.17 | 33.83 | 1.0300 | 0.7000 |
2019 | 64.31 | 35.69 | 0.7700 | 0.4500 |
2020 | 57.11 | 42.90 | 0.7300 | 0.4500 |
2021 | 59.53 | 40.47 | 0.8500 | 0.5500 |
2022 | 52.74 | 47.26 | 0.9100 | 0.5600 |
2023 | 54.22 | 45.79 | 0.8200 | 0.4400 |
2024 | 57.70 | 42.30 | 0.7800 | 0.4700 |
成本费用分析
类别\年份 | 营业成本 (元) |
销售费用 (元) |
管理费用 (元) |
财务费用 (元) |
2013 | 3271000000.0000 | 42369000.0000 | 203000000.0000 | 68456300.0000 |
2014 | 2983000000.0000 | 52397000.0000 | 217000000.0000 | 61445500.0000 |
2015 | 3516000000.0000 | 67771900.0000 | 268000000.0000 | 136000000.0000 |
2016 | 4309000000.0000 | 85166400.0000 | 326000000.0000 | 178000000.0000 |
2017 | 6048000000.0000 | 99258800.0000 | 255000000.0000 | 336000000.0000 |
2018 | 5734000000.0000 | 129000000.0000 | 373000000.0000 | 255000000.0000 |
2019 | 5041000000.0000 | 108000000.0000 | 380000000.0000 | 297000000.0000 |
2020 | 5990000000.0000 | 90331900.0000 | 364000000.0000 | 328000000.0000 |
2021 | 7002000000.0000 | 105000000.0000 | 370000000.0000 | 226000000.0000 |
2022 | 7132000000.0000 | 112000000.0000 | 563000000.0000 | 197000000.0000 |
2023 | 5721000000.0000 | 99781600.0000 | 363000000.0000 | 156000000.0000 |
2024 | 6263000000.0000 | 95811700.0000 | 328000000.0000 | 140000000.0000 |